本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (14413)
All Articles published online
|
Publishing Process of This Article
|
2018-02-28 (publication date) through 2025-01-30
本文章的被引频次
本文章的期刊信息
出版物名称
世界华人消化杂志
ISSN
1009-3079
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 高采平, 肖迅, 刘培曦, 周洲, 李良平, 韩盛玺. 大剂量阿莫西林/埃索美拉唑二联方案根除幽门螺杆菌. 世界华人消化杂志 2018; 26(6): 353-359 [DOI: 10.11569/wcjd.v26.i6.353] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v26/i6/353.htm |
| 编号 | Citing Articles |
| 1 |
Cheng Shen, Changping Li, Muhan Lv, Xiaosong Dai, Caiping Gao, Liangping Li, Qin Zhang, Wen Pan, Chao Liu, Sijing Han, Yang Zhang, Shunbin Ding, Hong Deng, Yong Yao, Jianyu Xu, Mingyong Wei, Haiyan Shi, Peijie Yuan, Xiaoyan Yang, Yi Jian, Jing Shan, Yan Liu, Zonghua Chen, Xuejie Deng, Fei Liu, Lijuan Deng, Xianfei Zhong, Hong Li, Shaoya He, Li Chen, Gang Liu, Hairong Xu, Yuquan Zhong, Hua Shi, Jiangang Ren.
The prospective multiple-centre randomized controlled clinical study of high-dose amoxicillin-proton pump inhibitor dual therapy for
H. pylori
infection in Sichuan areas
. Annals of Medicine 2022; 54(1): 426 doi: 10.1080/07853890.2022.2031269
|
| 2 |
Jing Li, Huiying Shi, Fang Zhou, Li Xie, Rong Lin. The Efficacy and Safety of Regimens for Helicobacter pylori Eradication Treatment in China. Journal of Clinical Gastroenterology 2024; 58(1): 12 doi: 10.1097/MCG.0000000000001902
|
| 3 |
Hui Wang, Qing Zhou Kong, Yue Yue Li, Xiao Yun Yang, Xiu Li Zuo. High‐dose dual therapy versus bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori: A systematic review and meta‐analysis. Journal of Digestive Diseases 2024; 25(3): 163 doi: 10.1111/1751-2980.13263
|
| 4 |
Chong Zhang, Jun Zhang, Yu-Jie Cheng. High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of helicobacter pylori infection: A meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology 2023; 29(2): 88 doi: 10.4103/sjg.sjg_532_22
|
| 5 |
Xue Yang, Jin-Xia Wang, Sheng-Xi Han, Cai-Ping Gao. High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment. Medicine 2019; 98(7): e14396 doi: 10.1097/MD.0000000000014396
|
| 6 |
Ben-Gang Zhou, Yu-Zhou Mei, Min Zhang, Xin Jiang, Yao-Yao Li, Yan-Bing Ding. High-dose dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis with trial sequential analysis. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848221147756
|
| 7 |
Qiuyue Huang, Zongming Shi, Hong Cheng, Hui Ye, Xuezhi Zhang. Efficacy and Safety of Modified Dual Therapy as the First-line Regimen for the Treatment of Helicobacter pylori Infection. Journal of Clinical Gastroenterology 2021; 55(10): 856 doi: 10.1097/MCG.0000000000001448
|
| 8 |
Yang-Jie Zhu, Yi Zhang, Ting-Yi Wang, Jing-Tao Zhao, Zhe Zhao, Jian-Ru Zhu, Chun-Hui Lan. High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820937115
|
| 9 |
Cai‐Ping Gao, Di Zhang, Ting Zhang, Jin‐Xia Wang, Sheng‐Xi Han, David Y. Graham, Hong Lu. PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis. Helicobacter 2020; 25(4) doi: 10.1111/hel.12692
|